These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31329050)

  • 1. Discovering Innovative Drugs Targeting Both Cancer and Cardiovascular Disease by Shared Protein-Protein Interaction Network Analyses.
    Tiwari S; Dwivedi UN
    OMICS; 2019 Sep; 23(9):417-425. PubMed ID: 31329050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating protein-protein interaction (PPI) networks for diseases pathway, target discovery, and drug-design using 'in silico pharmacology'.
    Chakraborty C; Doss C GP; Chen L; Zhu H
    Curr Protein Pept Sci; 2014; 15(6):561-71. PubMed ID: 25059326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature.
    Poornima P; Kumar JD; Zhao Q; Blunder M; Efferth T
    Pharmacol Res; 2016 Sep; 111():290-302. PubMed ID: 27329331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting protein-protein interactions as an anticancer strategy.
    Ivanov AA; Khuri FR; Fu H
    Trends Pharmacol Sci; 2013 Jul; 34(7):393-400. PubMed ID: 23725674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule binding sites to explore protein-protein interactions in the cancer proteome.
    Xu D; Jalal SI; Sledge GW; Meroueh SO
    Mol Biosyst; 2016 Oct; 12(10):3067-87. PubMed ID: 27452673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-based characterization of drug-regulated genes, drug targets, and toxicity.
    Kotlyar M; Fortney K; Jurisica I
    Methods; 2012 Aug; 57(4):499-507. PubMed ID: 22749929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics-based tools in drug discovery: the cartography from single gene to integrative biological networks.
    Ramharack P; Soliman MES
    Drug Discov Today; 2018 Sep; 23(9):1658-1665. PubMed ID: 29864527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gene Network Correlation Analysis of Obesity to Type 1 Diabetes and Cardiovascular Disorders: An Interactome-Based Bioinformatics Approach.
    D'Souza SE; Khan K; Jalal K; Hassam M; Uddin R
    Mol Biotechnol; 2024 Aug; 66(8):2123-2143. PubMed ID: 37606877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-protein interactions: network analysis and applications in drug discovery.
    Bultinck J; Lievens S; Tavernier J
    Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstructing genome-wide protein-protein interaction networks using multiple strategies with homologous mapping.
    Lo YS; Huang SH; Luo YC; Lin CY; Yang JM
    PLoS One; 2015; 10(1):e0116347. PubMed ID: 25602759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-level bioinformatics resources support drug target discovery of protein-protein interactions.
    Liu JX; Zhang X; Huang YQ; Hao GF; Yang GF
    Drug Discov Today; 2024 May; 29(5):103979. PubMed ID: 38608830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.
    Khunlertgit N; Yoon BJ
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):351. PubMed ID: 27766944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of Cancer Patients with Cardiovascular Complications - Onco-Cardiology].
    Mukai M
    Gan To Kagaku Ryoho; 2016 Aug; 43(8):940-4. PubMed ID: 27539035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases.
    Fang HY; Zeng HW; Lin LM; Chen X; Shen XN; Fu P; Lv C; Liu Q; Liu RH; Zhang WD; Zhao J
    Sci Rep; 2017 Mar; 7():43632. PubMed ID: 28272527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interacting partners of FEN1 and its role in the development of anticancer therapeutics.
    Kathera C; Zhang J; Janardhan A; Sun H; Ali W; Zhou X; He L; Guo Z
    Oncotarget; 2017 Apr; 8(16):27593-27602. PubMed ID: 28187440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-Protein Interaction (PPI) Network: Recent Advances in Drug Discovery.
    Athanasios A; Charalampos V; Vasileios T; Ashraf GM
    Curr Drug Metab; 2017; 18(1):5-10. PubMed ID: 28889796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemical libraries dedicated to protein-protein interactions].
    Sperandio O; Villoutreix BO; Morelli X; Roche P
    Med Sci (Paris); 2015 Mar; 31(3):312-9. PubMed ID: 25855285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.